News

Media and Political Bulletin – 09 July 2020

Media and Political Bulletin

09 July 2020

Media Summary

PSNC kicks off formal talks with government on Covid-19 funding for pharmacy

Pharmacy Business, Pri Mandav, 08 July 2020

Pharmacy Business reports that the Pharmaceutical Services Negotiating Committee (PSNC) has just announced that it has begun discussions with government on what it called “high-level community pharmacy costs and funding throughout the COVID-19 pandemic.”

Following several months of discussions with the NHS and the Department of Health, PSNC made a business case in April – based on data from other pharmacy bodies – for additional funding, outside of the £2.592bn global sum agreed for the Community Pharmacy Contractual Framework – to cover the Covid-19 related costs incurred by contractors and margin shortfalls.

PSNC warned that the wider sector would still need to collate data on additional costs on a monthly basis to help its negotiations with the government.

Parliamentary Coverage

House of Commons – Written Answer, 07 July 2020

Mr Richard Holden (North West Durham): To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on a transitional funding package for community pharmacists (a) before and (b) during the covid-19 outbreak.

Jo Churchill: In July 2019, we published our landmark five-year deal, ‘Community Pharmacy Contractual Framework’. This deal made £2.592 billion per year available to community pharmacy from 2019-20 to 2023-24. It was agreed in line with the Cabinet Office’s cross-Government collective agreement process.

The Department has had regular conversations with HM Treasury during the COVID-19 period about funding for community pharmacies. In addition to the unprecedented support package put in place for all businesses, further discussions are ongoing and we have agreed additional funding for a medicines delivery service for shielded patients and bank holiday openings.

Full Coverage

PSNC kicks off formal talks with government on Covid-19 funding for pharmacy

Pharmacy Business, Pri Mandav, 08 July 2020

The Pharmaceutical Services Negotiating Committee (PSNC) has just announced that it has begun discussions with government on what it called “high-level community pharmacy costs and funding throughout the COVID-19 pandemic.”

However, the news comes with a warning: the negotiation process “could last many more weeks”.

“Contractors have already been waiting many months for news on Covid-19 funding and it is frustrating that today’s news only begins the formal negotiations process, rather than giving them the answers they need,” Chief Executive Simon Dukes said on Wednesday (July 8).

However, now that the pharmacy negotiator has got the go-ahead from government to begin the formal negotiations, he assured contractors that PSNC would negotiate for the best outcome after assessing “HM Treasury’s views on pharmacy funding”.

Following several months of discussions with the NHS and the Department of Health, PSNC made a business case in April – based on data from other pharmacy bodies – for additional funding, outside of the £2.592bn global sum agreed for the Community Pharmacy Contractual Framework – to cover the Covid-19 related costs incurred by contractors and margin shortfalls.

It said DHSC and NHSE&I recognise the ‘significant effort’ made by the community pharmacy sector in supplying advice and medicines during the early stages of the pandemic and there is an acceptance that additional costs were incurred by the sector.

PSNC warned that the wider sector would still need to collate data on additional costs on a monthly basis to help its negotiations with the government.

Media and Political Bulletin – 09 July 2020

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?